Study of Insulin-like Growth Factor I in Liver Cells
Author Information
Author(s): Gentilini Alessandra, Lottini Benedetta, Brogi Marco, Caligiuri Alessandra, Cosmi Lorenzo, Marra Fabio, Pinzani Massimo
Primary Institution: Università degli Studi di Firenze, Florence, Italy
Hypothesis
The study aims to evaluate the involvement of key anti-apoptotic pathways in response to insulin-like growth factor I in activated human hepatic stellate cells.
Conclusion
Several anti-apoptotic pathways contribute to the resistance of human hepatic stellate cells to apoptosis, which is significant for liver fibrosis progression.
Supporting Evidence
- Insulin-like growth factor I induced activation of Akt and phosphorylation of Bad.
- Phosphorylation of GSK3 and FHKR was also observed after IGF-I treatment.
- IGF-I partially rescued hepatic stellate cells from apoptosis induced by strong stimuli.
Takeaway
The study found that a protein called insulin-like growth factor I helps liver cells avoid dying, which is important for understanding liver diseases.
Methodology
The study involved isolating human hepatic stellate cells and evaluating their response to insulin-like growth factor I through various biochemical assays.
Limitations
The study primarily focuses on human hepatic stellate cells in vitro, which may not fully represent in vivo conditions.
Participant Demographics
Human hepatic stellate cells isolated from surgical wedge sections of livers not suitable for transplantation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website